These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35082321)

  • 1. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers.
    van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM
    Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX7 target gene repression associates with FSHD progression and pathology over 1 year.
    Banerji CRS
    Hum Mol Genet; 2020 Aug; 29(13):2124-2133. PubMed ID: 32347924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level.
    Banerji CRS; Zammit PS
    Hum Mol Genet; 2019 Jul; 28(13):2224-2236. PubMed ID: 31067297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUX4 expressing immortalized FSHD lymphoblastoid cells express genes elevated in FSHD muscle biopsies, correlating with the early stages of inflammation.
    Banerji CRS; Panamarova M; Zammit PS
    Hum Mol Genet; 2020 Aug; 29(14):2285-2299. PubMed ID: 32242220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
    Banerji CRS; Zammit PS
    EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle.
    Banerji CRS; Panamarova M; Hebaishi H; White RB; Relaix F; Severini S; Zammit PS
    Nat Commun; 2017 Dec; 8(1):2152. PubMed ID: 29255294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
    Haynes P; Kernan K; Zhou SL; Miller DG
    Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.
    Wang LH; Friedman SD; Shaw D; Snider L; Wong CJ; Budech CB; Poliachik SL; Gove NE; Lewis LM; Campbell AE; Lemmers RJFL; Maarel SM; Tapscott SJ; Tawil RN
    Hum Mol Genet; 2019 Feb; 28(3):476-486. PubMed ID: 30312408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle.
    Yao Z; Snider L; Balog J; Lemmers RJ; Van Der Maarel SM; Tawil R; Tapscott SJ
    Hum Mol Genet; 2014 Oct; 23(20):5342-52. PubMed ID: 24861551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression.
    Wong CJ; Friedman SD; Snider L; Bennett SR; Jones TI; Jones PL; Shaw DWW; Blemker SS; Riem L; DuCharme O; Lemmers RJFL; van der Maarel SM; Wang LH; Tawil R; Statland JM; Tapscott SJ
    Hum Mol Genet; 2024 Apr; 33(8):698-708. PubMed ID: 38268317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
    Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL
    Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
    Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
    Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG
    PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development.
    van den Heuvel A; Mahfouz A; Kloet SL; Balog J; van Engelen BGM; Tawil R; Tapscott SJ; van der Maarel SM
    Hum Mol Genet; 2019 Apr; 28(7):1064-1075. PubMed ID: 30445587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.
    Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL
    Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics.
    Chen JC; King OD; Zhang Y; Clayton NP; Spencer C; Wentworth BM; Emerson CP; Wagner KR
    Mol Ther; 2016 Aug; 24(8):1405-11. PubMed ID: 27378237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies.
    Wong CJ; Wang LH; Friedman SD; Shaw D; Campbell AE; Budech CB; Lewis LM; Lemmers RJFL; Statland JM; van der Maarel SM; Tawil RN; Tapscott SJ
    Hum Mol Genet; 2020 Apr; 29(6):1030-1043. PubMed ID: 32083293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
    Tasca G; Pescatori M; Monforte M; Mirabella M; Iannaccone E; Frusciante R; Cubeddu T; Laschena F; Ottaviani P; Ricci E
    PLoS One; 2012; 7(6):e38779. PubMed ID: 22719944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. snRNA-seq analysis in multinucleated myogenic FSHD cells identifies heterogeneous FSHD transcriptome signatures associated with embryonic-like program activation and oxidative stress-induced apoptosis.
    Zheng D; Wondergem A; Kloet S; Willemsen I; Balog J; Tapscott SJ; Mahfouz A; van den Heuvel A; van der Maarel SM
    Hum Mol Genet; 2024 Jan; 33(3):284-298. PubMed ID: 37934801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.